vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $517.5M, roughly 1.6× WOLVERINE WORLD WIDE INC). WOLVERINE WORLD WIDE INC runs the higher net margin — 6.1% vs 0.5%, a 5.6% gap on every dollar of revenue. On growth, WOLVERINE WORLD WIDE INC posted the faster year-over-year revenue change (25.5% vs 7.5%). Over the past eight quarters, WOLVERINE WORLD WIDE INC's revenue compounded faster (14.5% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.
ACHC vs WWW — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $517.5M |
| Net Profit | $4.5M | $31.8M |
| Gross Margin | — | 47.3% |
| Operating Margin | — | 9.7% |
| Net Margin | 0.5% | 6.1% |
| Revenue YoY | 7.5% | 25.5% |
| Net Profit YoY | -50.8% | 162.8% |
| EPS (diluted) | $0.05 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $517.5M | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $470.3M | ||
| Q2 25 | $869.2M | $474.2M | ||
| Q1 25 | $770.5M | $412.3M | ||
| Q4 24 | $774.2M | $494.7M | ||
| Q3 24 | $815.6M | $440.2M | ||
| Q2 24 | $796.0M | $425.2M |
| Q1 26 | $4.5M | $31.8M | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $25.1M | ||
| Q2 25 | $30.1M | $26.8M | ||
| Q1 25 | $8.4M | $12.1M | ||
| Q4 24 | $32.6M | $23.1M | ||
| Q3 24 | $68.1M | $23.2M | ||
| Q2 24 | $78.5M | $13.8M |
| Q1 26 | — | 47.3% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 47.5% | ||
| Q2 25 | — | 47.2% | ||
| Q1 25 | — | 47.2% | ||
| Q4 24 | — | 43.4% | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 43.1% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 8.4% | ||
| Q2 25 | 5.8% | 8.6% | ||
| Q1 25 | 1.7% | 4.8% | ||
| Q4 24 | 4.9% | 7.4% | ||
| Q3 24 | 12.1% | 7.9% | ||
| Q2 24 | 13.4% | 6.8% |
| Q1 26 | 0.5% | 6.1% | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | 5.3% | ||
| Q2 25 | 3.5% | 5.7% | ||
| Q1 25 | 1.1% | 2.9% | ||
| Q4 24 | 4.2% | 4.7% | ||
| Q3 24 | 8.4% | 5.3% | ||
| Q2 24 | 9.9% | 3.2% |
| Q1 26 | $0.05 | $0.37 | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $0.30 | ||
| Q2 25 | $0.33 | $0.32 | ||
| Q1 25 | $0.09 | $0.15 | ||
| Q4 24 | $0.36 | $0.29 | ||
| Q3 24 | $0.74 | $0.28 | ||
| Q2 24 | $0.85 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | $621.7M |
| Stockholders' EquityBook value | $2.0B | $408.0M |
| Total Assets | $5.5B | $1.7B |
| Debt / EquityLower = less leverage | 1.29× | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | $621.7M | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $676.4M | ||
| Q2 25 | $2.3B | $708.5M | ||
| Q1 25 | $2.2B | $710.8M | ||
| Q4 24 | $2.0B | $648.0M | ||
| Q3 24 | $1.9B | $702.8M | ||
| Q2 24 | $1.8B | $814.7M |
| Q1 26 | $2.0B | $408.0M | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $376.7M | ||
| Q2 25 | $3.1B | $344.0M | ||
| Q1 25 | $3.0B | $310.6M | ||
| Q4 24 | $3.1B | $312.9M | ||
| Q3 24 | $3.0B | $295.2M | ||
| Q2 24 | $3.0B | $262.1M |
| Q1 26 | $5.5B | $1.7B | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $1.7B | ||
| Q2 25 | $6.3B | $1.8B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.8B |
| Q1 26 | 1.29× | 1.52× | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 1.80× | ||
| Q2 25 | 0.74× | 2.06× | ||
| Q1 25 | 0.72× | 2.29× | ||
| Q4 24 | 0.64× | 2.07× | ||
| Q3 24 | 0.62× | 2.38× | ||
| Q2 24 | 0.62× | 3.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $146.2M |
| Free Cash FlowOCF − Capex | — | $145.6M |
| FCF MarginFCF / Revenue | — | 28.1% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 13.78× | 4.60× |
| TTM Free Cash FlowTrailing 4 quarters | — | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | $146.2M | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $33.0M | ||
| Q2 25 | $133.5M | $44.6M | ||
| Q1 25 | $11.5M | $-83.8M | ||
| Q4 24 | $116.7M | $82.4M | ||
| Q3 24 | $163.1M | $108.2M | ||
| Q2 24 | $171.1M | $26.7M |
| Q1 26 | — | $145.6M | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $30.1M | ||
| Q2 25 | $-34.2M | $41.2M | ||
| Q1 25 | $-163.2M | $-91.4M | ||
| Q4 24 | $-86.8M | $74.4M | ||
| Q3 24 | $-27.1M | $104.1M | ||
| Q2 24 | $16.9M | $23.7M |
| Q1 26 | — | 28.1% | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 6.4% | ||
| Q2 25 | -3.9% | 8.7% | ||
| Q1 25 | -21.2% | -22.2% | ||
| Q4 24 | -11.2% | 15.0% | ||
| Q3 24 | -3.3% | 23.6% | ||
| Q2 24 | 2.1% | 5.6% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 0.7% | ||
| Q1 25 | 22.7% | 1.8% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 0.9% | ||
| Q2 24 | 19.4% | 0.7% |
| Q1 26 | 13.78× | 4.60× | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 1.31× | ||
| Q2 25 | 4.43× | 1.66× | ||
| Q1 25 | 1.37× | -6.93× | ||
| Q4 24 | 3.58× | 3.57× | ||
| Q3 24 | 2.39× | 4.66× | ||
| Q2 24 | 2.18× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
WWW
| Sales Channel Through Intermediary | $230.2M | 44% |
| Sales Channel Directly To Consumer | $142.6M | 28% |
| Work Group | $134.0M | 26% |
| Other | $10.7M | 2% |
